Ghevarsha International Tastylia Strips

Tastylia Orally Disintegrating Strips (ODS) or tadalafil sublingual technologies have drawn attention in the industry as a promising approach to deliver drugs in life cycle management to a wide range of the patient population. Those technologies promoted by Ghevarsha International are also aimed at patients incapable of swallowing pills, especially in modern populations. The criteria for rapid dissolution and onset of active ingredients in an ODS dosage depends on the performances of individual excipients which must qualify 3 unique criteria: hydrophilic in nature, dissolves quickly with good mouth feel, and is highly compressible. Identifying such excipients and/or technologies to meet these criteria could be challenging, especially to overcome the drug’s loading and stability. Currently, a wide spectrum of innovative, directly compressible co-processed excipients is available to meet these criteria for an ODS. The manufacturers of these excipients continue to invest in technologie